A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.
<h4>Background</h4>Coronavirus disease (COVID-19) negatively impacted tuberculosis (TB) programs which were already struggling to meet End-TB targets globally. We aimed to quantify and compare diagnosis, treatment initiation, treatment success, and losses along this TB care cascade for d...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850116542846468096 |
|---|---|
| author | Karen Jennings Martina Lembani Anneke C Hesseling Nyameka Mbula Erika Mohr-Holland Vanessa Mudaly Mariette Smith Muhammad Osman Sue-Ann Meehan |
| author_facet | Karen Jennings Martina Lembani Anneke C Hesseling Nyameka Mbula Erika Mohr-Holland Vanessa Mudaly Mariette Smith Muhammad Osman Sue-Ann Meehan |
| author_sort | Karen Jennings |
| collection | DOAJ |
| description | <h4>Background</h4>Coronavirus disease (COVID-19) negatively impacted tuberculosis (TB) programs which were already struggling to meet End-TB targets globally. We aimed to quantify and compare diagnosis, treatment initiation, treatment success, and losses along this TB care cascade for drug-susceptible TB in Cape Town, South Africa, prior to and during COVID-19.<h4>Methods</h4>This observational study used routine TB data within two predefined cohorts: pre-COVID-19 (1 October 2018-30 September 2019) and during-COVID-19 (1 April 2020-31 March 2021). The numbers of people diagnosed, treated for TB and successfully treated were received from the Western Cape Provincial Health Data Centre. Pre and post treatment loss to follow up and cascade success rates (proportion of individuals diagnosed with an outcome of treatment success) were calculated and compared across cohorts, disaggregated by sex, age, HIV status, TB treatment history and mode of diagnosis.<h4>Results</h4>There were 27,481 and 19,800 individuals diagnosed with drug-susceptible TB in the pre- and during-COVID-19 cohorts respectively, a relative reduction of 28% (95% CI [27.4% - 28.5%]). Initial loss to follow up increased from 13.4% to 15.2% (p<0.001), while post treatment loss increased from 25.2% to 26.1% (p < 0.033). The overall cascade success rate dropped by 2.1%, from 64.8% to 62.7% (p< 0.001). Pre- and during-COVID-19 cascade success rates were negatively associated with living with HIV and having recurrent TB.<h4>Conclusions</h4>An already poorly performing TB program in Cape Town was negatively impacted by the COVID-19 pandemic. There was a substantial reduction in the number of individuals diagnosed with drug-susceptible. Increases in pre-and post-treatment losses resulted in a decline in TB cascade success rates. Strengthened implementation of TB recovery plans is vital, as health services now face an even greater gap between achievements and targets and will need to become more resilient to possible future public health disruptions. |
| format | Article |
| id | doaj-art-5827ef1bec094cb7bf0e21052ee2ec82 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-5827ef1bec094cb7bf0e21052ee2ec822025-08-20T02:36:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01199e031038310.1371/journal.pone.0310383A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.Karen JenningsMartina LembaniAnneke C HesselingNyameka MbulaErika Mohr-HollandVanessa MudalyMariette SmithMuhammad OsmanSue-Ann Meehan<h4>Background</h4>Coronavirus disease (COVID-19) negatively impacted tuberculosis (TB) programs which were already struggling to meet End-TB targets globally. We aimed to quantify and compare diagnosis, treatment initiation, treatment success, and losses along this TB care cascade for drug-susceptible TB in Cape Town, South Africa, prior to and during COVID-19.<h4>Methods</h4>This observational study used routine TB data within two predefined cohorts: pre-COVID-19 (1 October 2018-30 September 2019) and during-COVID-19 (1 April 2020-31 March 2021). The numbers of people diagnosed, treated for TB and successfully treated were received from the Western Cape Provincial Health Data Centre. Pre and post treatment loss to follow up and cascade success rates (proportion of individuals diagnosed with an outcome of treatment success) were calculated and compared across cohorts, disaggregated by sex, age, HIV status, TB treatment history and mode of diagnosis.<h4>Results</h4>There were 27,481 and 19,800 individuals diagnosed with drug-susceptible TB in the pre- and during-COVID-19 cohorts respectively, a relative reduction of 28% (95% CI [27.4% - 28.5%]). Initial loss to follow up increased from 13.4% to 15.2% (p<0.001), while post treatment loss increased from 25.2% to 26.1% (p < 0.033). The overall cascade success rate dropped by 2.1%, from 64.8% to 62.7% (p< 0.001). Pre- and during-COVID-19 cascade success rates were negatively associated with living with HIV and having recurrent TB.<h4>Conclusions</h4>An already poorly performing TB program in Cape Town was negatively impacted by the COVID-19 pandemic. There was a substantial reduction in the number of individuals diagnosed with drug-susceptible. Increases in pre-and post-treatment losses resulted in a decline in TB cascade success rates. Strengthened implementation of TB recovery plans is vital, as health services now face an even greater gap between achievements and targets and will need to become more resilient to possible future public health disruptions.https://doi.org/10.1371/journal.pone.0310383 |
| spellingShingle | Karen Jennings Martina Lembani Anneke C Hesseling Nyameka Mbula Erika Mohr-Holland Vanessa Mudaly Mariette Smith Muhammad Osman Sue-Ann Meehan A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. PLoS ONE |
| title | A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. |
| title_full | A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. |
| title_fullStr | A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. |
| title_full_unstemmed | A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. |
| title_short | A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa. |
| title_sort | decline in tuberculosis diagnosis treatment initiation and success during the covid 19 pandemic using routine health data in cape town south africa |
| url | https://doi.org/10.1371/journal.pone.0310383 |
| work_keys_str_mv | AT karenjennings adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT martinalembani adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT annekechesseling adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT nyamekambula adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT erikamohrholland adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT vanessamudaly adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT mariettesmith adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT muhammadosman adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT sueannmeehan adeclineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT karenjennings declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT martinalembani declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT annekechesseling declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT nyamekambula declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT erikamohrholland declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT vanessamudaly declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT mariettesmith declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT muhammadosman declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica AT sueannmeehan declineintuberculosisdiagnosistreatmentinitiationandsuccessduringthecovid19pandemicusingroutinehealthdataincapetownsouthafrica |